FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for glyburide by Teva Pharmaceuticals USA, Inc. under ANDA074686.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)